Navigating Global Sunscreen Standards: ISO 24444 vs. FDA Monographs
Global expertise, personal touch
Offering a sunscreen product in several foreign markets can turn out to be a regulatory maze. Each region—including the USA, the European Union, and many Asian countries—has its own regulatory rules for sunscreen testing, labeling, and claims. For global brand players, knowledge of the distinction between ISO 24444:2019 and the FDA sunscreen monograph is essential for achieving complete sunscreen regulatory compliance.
While both systems primarily aim at consumer protection and correct SPF labeling, they differ significantly in testing methods, the degree of UVA protection required, and the regulatory classification of sunscreens. Comprehending international SPF standards is instrumental for producers to craft formulae that are in line with the rules and to prevent expensive product approval holdups.
Understanding ISO 24444:2019 and Its Global Role
ISO 24444:2019 is considered a worldwide standard for measuring the Sun Protection Factor (SPF) of sunscreen products. It specifies an in vivo testing procedure, which means that the product is tested on human volunteers in a laboratory under controlled conditions.
The test evaluates how well a sunscreen prevents erythema (sunburn) caused by ultraviolet radiation exposure. With this method:
- You apply a specified quantity of sunscreen to a small patch of human skin.
- Exposed both protected and unprotected skin to UV radiation generated by a solar simulator.
- Finally, researchers determine the minimal erythemal dose (MED)—the intensity of UV exposure resulting in redness of the skin.
SPF is obtained by the ratio of the UV dose leading to erythema in protected skin to the corresponding dose in unprotected skin. The method reflects how sunscreen works on human skin, making the results reliable.
The ISO 24444 standard is followed in several territories, such as:
- the European Union,
- Australia and New Zealand,
- Japan and Korea,
- ASEAN countries,
- Canada and other developing markets.
The protocol has been embraced by almost 60 countries worldwide. Therefore, it is regarded as one of the most extensively recognized international SPF standards.
The FDA Sunscreen Monograph: A Different Regulatory Approach
Even though standards developed by ISO are aligned worldwide, the U.S. has its own regulatory system through the FDA sunscreen monograph.
According to the FDA’s system, sunscreens are treated as over-the-counter (OTC) drugs, not as cosmetics. As a result, there are more rigorous drug-type requirements, including ingredient approval, labeling, and clinical testing.
The FDA SPF measurement is a lot like ISO 24444 since it also involves in vivo human testing to determine the level of protection against erythema. However, there are a number of extra provisions for making label claims, such as “Broad Spectrum” protection.
First and foremost, in order to be called a Broad Spectrum sunscreen in the U.S., a product is required to undergo a second in vitro UVA test that evaluates its absorbance at different wavelengths of the UV spectrum. In fact, the sunscreen has to have a critical wavelength of at least 370 nm.
Additionally, the FDA regulates:
- Water resistance claims (40 or 80 minutes)
- Standardized “Drug Facts” labeling
- Approved active UV filter ingredients
Such a regulatory framework illustrates the FDA’s drug-characteristic-centered approach with respect to sunscreen products.
Key Differences Between ISO and FDA Standards
Even though both systems calculate SPF, their regulatory philosophies and technical requirements are quite different.
1. Product Classification
The major difference between the two systems is the way sunscreens are classified and categorized.
- United States: FDA considers sunscreens as OTC drugs under the drug monograph.
- Europe and most international markets: Sunscreens are considered and regulated as cosmetic products.
This classification impacts the timelines for ingredient approval, the marketing claims, and the product development strategies.
2. UVA Protection Requirements
Another huge distinction is how UVA protection is rated at UVA. For one, in America, broad-spectrum protection is judged for the most part by the critical wavelength test that initiates by checking whether the sunscreen blocks enough UVA across the spectrum. A wavelength of 370 nm is the criterion to be able to market as broad-spectrum protection.
By and large, European and many other international standards insist on there being a balance of UVA and UVB protection. According to a European law, the product shall:Critical wavelength ≥ 370 nm. The level of UVA protection factor (UVA-PF) shall be at least one-third of the SPF value. (EWG)
This way, one can better get assurance that the products will be able to give good protection against both UVA and UVB rays.
3. SPF Testing Methodology
Both ISO and FDA standards require in vivo SPF assessment on human subjects. On the other hand, ISO 24444 offers a worldwide harmonized technique aimed at reducing differences in test results from different laboratories.
Some major elements of the ISO protocol are:
- The test is performed on a group of volunteers
- The UV rays to which the skin is exposed are controlled with the help of solar simulators
- The skin's reaction to the UV irradiation (erythema) is checked after 16 to 24 hours. (The ANSI Blog)
The FDA method also involves the use of similar steps, but goes further by prescribing additional binding regulatory conditions related to drug product testing and labeling.
Regulatory Landscape Across Major Markets
Regulatory environments for brands going international vary greatly from one region to another.
United States
- FDA sunscreen monograph is the main regulatory document
- Sunscreens categorized as over-the-counter (OTC) drugs
- The ingredient approval process is very rigorous
- For the Broad Spectrum claim, the critical wavelength should be ≥ 370 nm
European Union
- Sunscreens are treated as cosmetics
- SPF test done following ISO 24444 standard
- UVA protection has to comply with the UVA-PF/SPF ≥ 1/3 rule
Asia-Pacific Markets
Several Asian markets, including Japan, Korea, and ASEAN countries, base their testing methods on ISO, and, in addition to that, labeling systems such as PA ratings are used for UVA protection.
Since these regulatory requirements differ, brands may have to undertake several validation tests in order to substantiate their claims in various markets.
Why Testing Laboratories Are Essential for Global Launches
Manufacturers often collaborate with specialized laboratories for testing and regulatory guidance due to the complicated nature of international sunscreen regulations.
These photobiology testing services providers can help with:
- Performing in vivo SPF tests (ISO 24444)
- Analyzing UVA protection
- Evaluating broad-spectrum capabilities
- Testing for water resistance
- Preparing regulatory documentation for worldwide submissions
Testing providers such as Eurofins offer advanced photobiology services that are tailor-made to help with your sunscreen R&D and getting your products approved by authorities in multiple regions.
Just by choosing the right experienced lab to partner with, brands will be able to obtain validated data that complies with both FDA requirements and international SPF standards.
Best Practices for Brands Launching Globally
Companies planning international sunscreen launches should consider several regulatory strategies.
Design Formulations with Global Compliance in Mind
Using UV filters that have been approved in various jurisdictions can minimize the times of reformulating products when entering new markets.
Conduct Dual Testing
Performing both ISO-based SPF tests and FDA-compliant evaluations is the most straightforward way to meet the requirements of all regulatory bodies worldwide.
Verify UVA Protection Early
Developing a formula that accurately combines effective UVA and UVB protection will circumvent any last-minute compliance problems.
Maintain Robust Documentation
Usually, regulatory authorities request an extensive amount of documentation, such as testing reports, clinical protocols, and validation data, to make their decisions.
Conclusion
Understanding the variations in international SPF standards is a key aspect of identifying the clues of different regulators within a market. In particular, the ISO 24444:2019 standard lays down an internationally harmonized method of SPF testing, which is primarily used in Europe, Asia, and lots of other international markets. However, the FDA sunscreen monograph not only controls sunscreen products in the United States but also regulates them with stricter drug-style regulations, and it has different UVA testing requirements.
For companies planning to launch their products worldwide, complying with the sunscreen regulations means modifying the ways of formulation as per these varying testing protocols. Through extensive photobiology testingand partnering with knowledgeable laboratories, manufacturers can develop products that meet the expectations of regulators in different markets, which, in the end, results in successful global product launches.
Let's Connect
We deliver quality in all of our work, providing accurate results on time.
